A Detailed Look at Cannabis Sales in California, Oregon, Arizona, Colorado and Nevada
Data provided by BDSA indicates that cannabis sales continued their robust expansion in 5 Western states, though seasonal trends resulted in declines from the prior month. During October, the first first full month after the anniversary of the vaping crisis and the eighth month of the pandemic impacting the market, sales across the five markets totaled $791 million, down 2% from September, which followed sequential declines of 4% in August and 1% in July, and sequential increases of 12% in June, 2% in May and 14% in April. March had spiked dramatically to $666.0 million from $579.9 million in February as customers purchased cannabis ahead of store closures and concerns about limitations on access. With the near-term effects of the pandemic now behind us, it’s clear that cannabis demand is surging, even in relatively mature markets, like Oregon and Colorado.
Overall sales growth from a year ago among the five Western markets ranged from 30% in California to as high as 39%% in Arizona and Oregon. Colorado grew 34%, while Nevada increased 32%. The largest market, California, posted strong gains for the fourth consecutive month after a long period of being relatively flat growth. Note that the comparisons to a year ago were easier given that the sales began to be impacted negatively by the vaping crisis a year ago, but, with the exception of Oregon, growth in flower exceeded growth in concentrates in all markets.
Here is a closer look at each market, as detailed by BDSA:
In October 2020, cannabis sales in Arizona’s medical dispensaries reached $89.3 million, growing nearly five percent from September. Compared to the previous October, sales in Arizona grew almost 39 percent. Year-to-date through October, sales have reached $856.1